Jarushka Naidoo
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Jarushka Naidoo
Jul 25, 2024, 00:32 |
Blog
Jarushka Naidoo: Can intratumor eschericia improve OS from ICIs in NSCLC
Jarushka Naidoo shared a post on X: ''Can intratumor eschericia (E) bring immune cells to…
Jul 22, 2024, 02:59 |
Blog
CtDNA Analysis on Osimertinib in FLAURA and AURA3 trials
Jarushka Naidoo shared a post on X about an article by Jhanelle Gray et al. titled…
Jul 21, 2024, 20:02 |
Blog
Biagio Ricciuti: Join us in Lausanne for the 2024 International Lung Cancer Summit
Biagio Ricciuti shared a post on X by the International Lung Cancer Summit, adding: "Join…
Jul 7, 2024, 17:43 |
Insight
Jarushka Naidoo: ctDNA+ associates with outcomes in stage III unresectable NSCLC
Jarushka Naidoo shared a post on X: “ctDNA+ in consolidation IO trial (BTCRC 16-081) associates…
Jul 7, 2024, 15:44 |
Blog
Francesco Cortiula: What evidences for the treatment of patients with stage III NSCLC excluded from trials?
Francesco Cortiula, Medical Oncologist at University Hospital of Udine, made the following post on X:…
Jul 3, 2024, 14:37 |
Insight
Jarushka Naidoo: Phase III RESILIENT Trial of Liposomal Irinotecan v Topotecan in 2L SCLC
Jarushka Naidoo shared a post on X: “Phase III RESILIENT Trial of Liposomal Irinotecan v…
Jun 21, 2024, 04:59 |
Insight
Jarushka Naidoo: WCLC24 is fast approaching
Jarushka Naidoo shared a post by IASLC on X, adding: “WCLC24 is fast approaching! Look…
Jun 19, 2024, 03:23 |
Blog
Alessio Cortellini: A great honor to be invited to the amazing Tbilisi to discuss irAEs-management
Alessio Cortellini, Assistant Professor at Campus Bio-Medico University of Rome, shared a post on LinkedIn: …
Jun 19, 2024, 02:56 |
Blog
Jarushka Naidoo: With Georgian Oncology community at a national meeting on irAEs
Jarushka Naidoo shared on LinkedIn: . “Thank you to the Georgian Oncology community for…
Jun 18, 2024, 18:00 |
Insight
Elene Mariamidze: The ESMO reunion in Tbilisi, Georgia
Elene Mariamidze, Medical/Clinical Oncologist at Todua Clinic, shared the following post on X: “The ESMO…
Jun 18, 2024, 05:57 |
Blog
Alessio Cortellini: Jarushka Naidoo on the management of Immune-Related Adverse Events
Alessio Cortellini, Consultant Medical Oncologist at the Campus Bio-Medico University of Rome, shared on X:…
Jun 12, 2024, 05:36 |
Insight
Jarushka Naidoo: Can a cfDNA fragmentomic assay assist in lung cancer screening?
Jarushka Naidoo shared on X/Twitter: "Can a cfDNA fragmentomic assay assist in lung cancer screening?…
Jun 10, 2024, 11:09 |
Insight
Phase II BLOSSOM Trial Osimertinib in LMD from EGFR+ NSCLC by Sehhoon Park et al.
Jarushka Naidoo shared a post on X: "Phase II BLOSSOM Trial Osimertinib in LMD (leptomeningeal…
Jun 2, 2024, 09:09 |
Societies
15 Posts From ASCO24 Day 2 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 31, 2024, 16:42 |
Blog
Jarushka Naidoo: My Top 5 Targeted Therapy abstracts at ASCO24 with key data where available
Jarushka Naidoo shared a post on X: "ASCO24 is tomorrow! Lung Cancer Abstracts not to missed,…
May 25, 2024, 09:19 |
Blog
Giannis Mountzios: Don't miss our ASCO24 session on Beyond Chemo-IO in NSCLC
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital…
May 21, 2024, 12:01 |
Blog
Jarushka Naidoo: Phase III trial methylphenidate versus placebo for cancer fatigue in advanced solid tumors
Jarushka Naidoo shared on X/Twitter: "Phase III trial methylphenidate versus placebo for cancer fatigue in advanced…
May 18, 2024, 09:06 |
Blog
Jarushka Naidoo: Perioperative Nivolumab in Stage IIA-IIIB NSCLC
Jarushka Naidoo shared on X/Twitter: ''Ph III CM77T trial at NEJM: Perioperative Nivolumab in Stage…
May 13, 2024, 14:29 |
Insight
Jarushka Naidoo: A step forward in implementing anti-PD(L)1 across growing not otherwise specified of indications?
Jarushka Naidoo shared on X: "Ph III IMscin001 trial of Subcutaneous (sc) vs IV Atezolizumab…
May 12, 2024, 07:32 |
Blog
Jarushka Naidoo: The IASLC's WCLC25 co-chairs are together in Rome
Jarushka Naidoo shared on X: "The International Association for the Study of Lung Cancer's WCLC25…
May 12, 2024, 03:12 |
Blog
Misty Dawn Shields: Groundbreaking study challenging the dogma of 'YAP1' neuroendocrine subtype in SCLC
Misty Dawn Shields, Assistant Professor of Clinical Medicine, Division of Hematology/Oncology at IU School of…
May 9, 2024, 14:13 |
Insight
Jarushka Naidoo: Interesting multi-omic analysis of previously classified SCLC cell lines
Jarushka Naidoo shared a post on X: “Interesting multi-omic analysis of previously classified Small Cell Lung…
May 9, 2024, 06:46 |
Societies
12 Posts Not To Miss From The 3rd International Summit on Lung Cancer!
The 3rd International Summit on Lung Cancer (RomeLung24), organized by the International Association for the…
May 8, 2024, 00:20 |
Blog
Jarushka Naidoo: Tony Mok on neoadj chemoIO at RomeLung24
Jarushka Naidoo shared a post on X: "RomeLung24 Tony Mok presents key insights on neoadj chemoIO…
May 5, 2024, 00:58 |
Blog
Jarushka Naidoo: Oncology in the 21st century' session at the academic intern showcase RCSI University of Medicine and Health Sciences
Jarushka Naidoo shared a post by ICAT Programme on X, adding the following: “A privilege…
May 3, 2024, 06:29 |
Blog
Jarushka Naidoo: Official pics of the All Ireland Lung Cancer Conference 2024
Jarushka Naidoo shared on X/Twitter: "Official pics of the All Ireland Lung Cancer Conference 2024…
Apr 30, 2024, 19:20 |
Blog
Jarushka Naidoo: Join us on International Clinical Trials Day
Jarushka Naidoo shared the following post on X: “May 9 is International Clinical Trials Day…
Apr 29, 2024, 14:48 |
Insight
Lynn M. Schuchter: Jarushka Naidoo is an exemplar of the ASCO LDP Program
Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and director of the University of…
Apr 29, 2024, 14:08 |
Blog
Jarushka Naidoo: Progress is afoot at Joint Euro US Cancer Forum
Jarushka Naidoo, shared a post on X: “Thanks to superb speakers of the lung cancer…
Apr 23, 2024, 23:25 |
Drugs
Jarushka Naidoo: Pooled 5-year outcomes of Pembrolizumab and Chemotherapy for PDL less than 1% metastatic NSCLC in the Journal of Thoracic Oncology
Jarushka Naidoo shared on X: “Pooled 5-yr outcomes of Pembrolizumab and Chemotherapy for PDL1<1% metastatic…
Apr 18, 2024, 14:58 |
Blog
Jarushka Naidoo: A wonderful weekend with lung cancer leaders and friends at AILCC24
Jarushka Naidoo recently shared on LinkedIn: "A wonderful weekend with lung cancer leaders and friends…
Apr 16, 2024, 01:50 |
Blog
Jarushka Naidoo: Starting day 2 with Patrick Forde on periop chemo-IO in nsclc
Jarushka Naidoo shared on X/Twitter: "AILCC24 Starting day 2 with Patrick Forde on periop chemoIO in nsclc.…
Apr 14, 2024, 07:51 |
Insight
New Paper Alert! Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach
Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach Published in Journal for ImmunoTherapy of Cancer,…
Apr 11, 2024, 13:50 |
Insight
New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo - LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter: "50% patients develop side effects from immunotx. New blood test predicts…
Apr 3, 2024, 15:42 |
Drugs
Jarushka Naidoo: Phase II trial of Tumor-Infiltrating Lymphocyte (TIL) therapy (Lifileucel) in Advanced Non-Small Cell Lung Cancer post Immunotherapy with or without chemotherapy
Apr 1, 2024, 23:46 |
Insight
Jarushka Naidoo: Spectrum of ICI toxicity in last 10 years
Jarushka Naidoo shared on X/Twitter: "Spectrum of ICI toxicity in last 10 years: - Vigibase…
Mar 29, 2024, 18:40 |
Insight
Jarushka Naidoo: Ph III KRYSTAL-12 Trial of 2nd-line Adagrasib in KRAS G12C+ NSCLC meets primary PFS endpoint
Jarushka Naidoo shared on X/Twitter: "Ph III KRYSTAL-12 Trial of 2nd-line Adagrasib in KRAS G12C+…
Mar 27, 2024, 14:11 |
Blog
Stephen V Liu: ELCC24 Great discussion of Antibody drug conjugates toxicity from Dr. Jarushka Naidoo, noting that each component of the antibody drug conjugate will impact toxicity
Mar 25, 2024, 15:15 |
Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
Mar 25, 2024, 15:09 |
Insight
Jarushka Naidoo: Surgical outcomes of RATIONALE-315 (Neoadjuvant Tis + chemo in resectable NSCLC)
Jarushka Naidoo recently posted on X: "Surgical outcomes of RATIONALE-315 (Neoadjuvant Tis+chemo in resectable NSCLC): -…
Mar 24, 2024, 23:26 |
Blog
Jarushka Naidoo: ESMO Young Oncologists (YO) session on career navigation with Herbert Loong, Lizza Hendriks, Alfredo Addeo & I
Jarushka Naidoo shared a post on X: “ELCC24 ESMO Young Oncologists (YO) session on career…
Mar 22, 2024, 18:47 |
Blog
Alessandra Fontecedro: The first Swiss Oncology Summer School
Alessandra Fontecedro, Head Medical Oncology at HFR Fribourg Hospital, shared on LinkedIn: "To medical students:…
Mar 21, 2024, 16:18 |
Blog
Sumanta Pal: Always appreciate that Shankar Siva goes the extra mile(s) to support his medical oncology colleagues
Sumanta Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared a…
Mar 21, 2024, 15:19 |
Blog
Jarushka Naidoo: Getting ready to plan ASCO24
Jarushka Naidoo shared a post on X/Twitter: “Getting ready to plan ASCO24! And with a…
Mar 15, 2024, 18:02 |
Insight
Jarushka Naidoo: Join us All at Ireland Lung Cancer Conference On 12-13 April 2024
Jarushka Naidoo shared a post on X/Twitter: "All Ireland Lung Cancer Conference: Privileged to be…
Mar 12, 2024, 20:33 |
Insight
Jarushka Naidoo: Is chemo-ICI or ICI preferable, in patients older than 75yrs with advanced NSCLC?
Jarushka Naidoo shared on X/Twitter: "Is chemo-ICI or ICI preferable, in pts >75yrs with advanced…
Mar 11, 2024, 18:00 |
Societies
Florez Lab: A fantastic discussion on Nivolumab and Non-Small Cell Lung Cancer
Florez Lab posted on X/Twitter: "What podcast should you listen to today? In this episode…
Mar 10, 2024, 12:08 |
Blog
Jarushka Naidoo: Outcomes of patients with G2+ Pneumonitis on the PACIFIC trial JTO and JTO CRR
Jarushka Naidoo shared a post on her X/Twitter page: “Pleased to publish outcomes of patients…
Feb 17, 2024, 18:19 |
Societies
The IASLC named co-chairs of the IASLC WCLC25 - IASLC
IASLC posted on X/Twitter: "Press Release: The IASLC today named Umberto Malapelle, Jarushka Naidoo, Isabelle…
Feb 7, 2024, 12:46 |
Blog
Amin Nassar presents the results of a multicenter retrospective cohort for osimertinib and durvalumab in unresectable EGFR-mutant NSCLC
Amin Nassar, Hematology/Oncology Fellow at Yale University, shared a post on X/Twitter: "1. Pumped to…
Feb 2, 2024, 05:47 |
Blog
Jarushka Naidoo: Save the date for the 11th All-Ireland Lung Cancer Conference
Jarushka Naidoo recently shared on LinkedIn: "Save the date for the 11th All-Ireland Lung Cancer…
Feb 1, 2024, 15:31 |
Opinion
Jarushka Naidoo: Congrats to super fellow David McMahon on his paper addressing a timely topic in thoracic oncology
Jarushka Naidoo shared a post on her X/Twitter page: "Congrats to super fellow David McMahon…
Feb 1, 2024, 14:12 |
Blog
Amin Nassar: Our Multicenter Retrospective Cohort Study' is now out in JTO!
Amin Nassar, Hematology/oncology fellow at Yale University, shared a post on X/Twitter: "Pumped to share…
Nov 30, 2023, 07:19 |
Blog
Jarushka Naidoo: Great to spend the day with the Danish young oncologists society, learning about immunotherapy toxicity
Jarushka Naidoo shared a post by FYO on X/Twitter, adding: "Great to spend the day…
Nov 21, 2023, 16:56 |
Blog
Jarushka Naidoo: Super talk by Charo Campelo on systemic therapy in the periop NSCLC space
Quoting Jarushka Naidoo, a Professor of Medical Oncology at the Royal College of Surgeons in Ireland…
Oct 23, 2023, 13:26 |
Insight
Marcelo Corassa: Great presentation by the amazing Jarushka Naidoo on the promises and pitfalls of neoadjuvant therapy for NSCLC
Marcelo Corassa, Medical oncologist and Clinical Researcher at Beneficência Portuguesa de São Paulo, shared on…
Oct 7, 2023, 17:20 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 7
We continue OncoDaily’s '100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social…
Sep 7, 2023, 19:38 |
Insight
Jarushka Naidoo: The secret to a long life as a clinician scientist is the same as a long marriage.
Quoting Jarushka Naidoo, a Professor of Medical Oncology at the Royal College of Surgeons in Ireland…
Aug 10, 2023, 18:37 |
Career
Nominating committee of ESMO - Jarushka Naidoo
Kudos to Rebecca Dent as chair, and Dr.Toni Choueiri, Helena Linardou, Dr. Angela Lamarca, Dr. Christophe…
All:
59
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube